| Literature DB >> 1451646 |
G Mathé1, J L Misset, B K Triana, D Godenèche, J C Madelmont, G Meyniel.
Abstract
A trial of cystemustine, a cysteamine nitrosourea, was carried out on 34 patients with advanced malignancies at increasing dosage of the drug over a period of up to 190 days in seven or eight cycles. A partial response to treatment was obtained in three patients. A degree of haematological toxicity developed in a number of the patients.Entities:
Mesh：
Substances：
Year: 1992 PMID： 1451646
Source DB: PubMed Journal: Drugs Exp Clin Res ISSN： 0378-6501